Navigation Links
Stroke-preventing technology demonstrated in JoVE
Date:2/28/2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be affected by 2050. The most devastating side effect of AF is stroke, but a new device from Boston Scientific may prevent them from occurring.

Researchers from Atritech, now part of Boston Scientific, developed the WATCHMAN device, a small mesh umbrella that can be inserted into part of the heart cavity to prevent the formation of blood clots that cause strokes.

Currently, the anti-coagulant drug warfarin is used to prevent strokes, but the drug comes with other risks.

Warfarin has a lot of side-effects. One major side-effect is the bleeding risk, said paper author Dr. Sven Mobius-Winkler. Therefore, only 50 percent of the patients who should take Warfarin actually take it.

The WATCHMAN device gives patients another option. It has already been approved for use in the European Union and Australia, and secured investigational approval from the FDA in 2009.

To help train doctors how to use the device, doctors from the University of Leipzig Heart Center in Germany are publishing the full WATCHMAN placement procedure in the Journal of Visualized Experiments (JoVE), the worlds first and only peer-reviewed, PubMed indexed, science and medicine video journal.

Intervention and closure of the left atrial appendage is a complex procedure, said Dr. Mobius- Winkler. For inexperienced physicians, it is hard to learn this procedure and therefore the video can help by doing step-by-step the implantation.

The WATCHMAN device will give patients with atrial fibrillation another option rather than anti-coagulant drugs, said JoVE Editor Dr. Robert Dolan. This article demonstrates the implantation of the device and will help clinicians gain expertise with the procedure, helping many of the patients who are unable or unwilling to take warfarin.


'/>"/>

Contact: Katherine Scott
katherine.scott@jove.com
617-820-1817
The Journal of Visualized Experiments
Source:Eurekalert  

Related medicine news :

1. Development of social technology to improve the quality of life of intellectually disabled people
2. New technology to tackle treatment-resistant cancers
3. Research finds newer radiation therapy technology improves patients quality of life
4. American College of Physicians, CECity launch new quality improvement technology platform
5. Patients at risk of knee joint complications when new technology is used
6. Notre Dame, Purdue and GE Healthcare partner on new CT technology
7. Indevr launches breakthrough colorimetric detection for microarrays using core technology from CU
8. Combined arterial imaging technology reveals both structural and metabolic details
9. Health Information Technology and Patient Safety - IOM report releases Nov. 10
10. Modern Technology Reveals Clues From Egyptian Mummy
11. Federal government releases environmental, health, and safety research strategy for nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stroke-preventing technology demonstrated in JoVE
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: